Scarica l'app Stockscreener
3.16
0.32%
-0.010
Precedente Chiudi:
$3.17
Aprire:
$3.18
Volume 24 ore:
65,702
Relative Volume:
0.06
Capitalizzazione di mercato:
$4.80M
Reddito:
$502.40K
Utile/perdita netta:
$-7.91M
Rapporto P/E:
-0.3169
EPS:
-9.972
Flusso di cassa netto:
$-4.32M
1 W Prestazione:
+1.94%
1M Prestazione:
+62.05%
6M Prestazione:
-39.23%
1 anno Prestazione:
-79.08%
Intervallo 1D:
$3.02
$3.2998
Intervallo di 1 settimana:
$2.85
$3.85
Portata 52W:
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Confronta SXTP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
3.16 | 4.80M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Short Interest Down 43.2% in March - Defense World
Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday? - MSN
60 Degrees Pharma's Breakthrough: New Clinical Trials Target Rising Tick-Borne Disease Crisis - Stock Titan
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21 - Yahoo Finance
10 Stocks Fall Behind Amid Market Optimism - Insider Monkey
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
60 Degrees and Yale to progress tafenoquin for babesiosis - Yahoo
60 Degrees Pharmaceuticals (SXTP) Reports 2024 Financial Results - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Announces 1-for-5 Reverse Stoc - GuruFocus
60 Degrees Pharma signs patent agreement with Yale for tick disease medicine development - Mugglehead Magazine
60 Degrees Pharmaceuticals signs Patient License Agreement with Yale - TipRanks
TNF Pharmaceuticals Inc: Navigating Market Fluctuations with a 0.75M Market Cap - investchronicle.com
60 Degrees Pharmaceuticals partners with Yale for drug development By Investing.com - Investing.com South Africa
Traders boost bets Fed will start cutting rates in May - Yahoo Finance
Mr. Yoshida's Brings the Heat with New Spicy Wing & Rib Sauce - Yahoo Finance
InventHelp Inventor Develops New Litter Removal Tool for Poultry Houses (JTK-236) - Yahoo Finance
60 Degrees Pharmaceuticals (SXTP) Stock Rallies On Tafenoquine Patent News - Stocks Telegraph
Will Assurant (AIZ) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Donaldson Exhibits Strong Prospects Despite Persisting Headwinds - Yahoo Finance
US trade rep says Trump tariffs are getting results, but things may be 'challenging' for awhile - Yahoo Finance
US Tariff Revenue Gains Seen as Undercut by Declining Trade - Yahoo Finance
SSL or XOM: Which Is the Better Value Stock Right Now? - Yahoo Finance
RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study - Yahoo Finance
Watch live: U.S. Trade Rep. Jamieson Greer testifying before Senate Finance Committee - Yahoo
60 Degrees Pharmaceuticals (SXTP) Teams with Yale for Tafenoquine Development - GuruFocus
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
60 Degrees Pharmaceuticals Signs Patent License Deal to Develop Tafenoquine for Tick-Borne Disease Treatment - marketscreener.com
Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine - MarketScreener
60 Degrees Pharmaceuticals: Surge or Slump Ahead? - timothysykes.com
SXTP60 degrees pharmaceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
60 Degrees Pharmaceuticals partners with Yale for drug development - Investing.com
First-Ever Babesiosis Prevention Drug: Yale Partners with Sixty Degrees on Breakthrough Treatment - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Trump’s Tariff Guru Gives His Personal ‘Guarantee’ There Won’t Be a Recession - Yahoo News
These Bond ETFs Are Still Winning Amid Trump Tariff Selloff - Yahoo Finance
Indian fintech Juspay secures $60m in Series D funding - Yahoo Finance
Laurentian Bank shares an update on the progress of its strategic plan - The Globe and Mail
ECB's Stournaras says higher inflation due to tariffs could delay monetary policy normalisation - Yahoo Finance
Influential China Bloggers Post Options to Hit Back at Trump - Yahoo Finance
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment - The Globe and Mail
1 Unstoppable Tariff-Proof Growth Stock to Buy Hand Over Fist During the S&P 500 Correction - The Globe and Mail
Will MasterCard (MA) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R) - ACCESS Newswire
Here's Why Enterprise Products Partners (EPD) is a Strong Value Stock - Yahoo Finance
US stock market today: Stock futures continue to plunge on Monday amid Trump tariffs - Yahoo
Recursion Pharmaceuticals (NasdaqGS:RXRX) Sees 27% Weekly Drop After Leadership Changes - Yahoo Finance
DuPont Introduces Liveo Pharma TPE Ultra-Low Temp Tubing - Yahoo Finance
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024 - Yahoo Finance
VSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market - Quantisnow
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree - Yahoo Finance
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
| XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):